A Deep Learning Model for Blood Volume Estimation From Multi-modal Ultrasound
Quantitative Estimation of Preoperative Blood Volume Using Multi-modal Ultrasound and Deep Learning
1 other identifier
observational
800
1 country
2
Brief Summary
- 1.Background \& Rationale:
- 2.Objective:
- 3.Study Design:
- 4.Methods:
- 5.Expected Outcome \& Significance:
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 26, 2025
CompletedFirst Posted
Study publicly available on registry
May 4, 2025
CompletedStudy Start
First participant enrolled
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2027
November 17, 2025
November 1, 2025
1.8 years
April 26, 2025
November 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Quantitative estimation of blood volume
We will estimate the basic blood volume of the patients quantitatively with the Acute Hemodilution technique before the surgery.
within 30mins before the surgery
Study Arms (1)
patients prepare to receive surgery
The patients aged 18-75 years old prepare to receive surgery will be assigned into the cohort.
Eligibility Criteria
Patients prepare to receive surgery.
You may qualify if:
- Agree to join this study and sign the informed consent form;
- Age between 18 and 75 years old (inclusive);
- BMI (body mass index) is between 18 and 30 kg/m2;
- American Society of Anesthesiologists (ASA) grades I-II
You may not qualify if:
- Preoperative hemoglobin (Hb) \<10g/dl
- Cardiac dysfunction (NYHA class III-IV), respiratory dysfunction (ATS class 2-4), history of liver and kidney dysfunction (such as transaminase / albumin / bilirubin abnormalities, hepatitis history, serum creatinine / urea nitrogen rise, etc.), nervous system abnormalities (those who cannot cooperate due to stroke or its sequelae, Alzheimer, etc.);
- The ultrasonic display of inferior vena cava, internal jugular vein, subclavian vein or common carotid artery is extremely poor, venous thrombosis or anatomical abnormalities;
- Multiple injury with chest, abdomen or brain;
- Pregnant woman
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Shanghai, Shanghai Municipality, 200235, China
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Shanghai, Shanghai Municipality, 200235, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- attending doctor
Study Record Dates
First Submitted
April 26, 2025
First Posted
May 4, 2025
Study Start
October 1, 2025
Primary Completion (Estimated)
July 31, 2027
Study Completion (Estimated)
August 31, 2027
Last Updated
November 17, 2025
Record last verified: 2025-11